Florida Firm's OTC Tattoo Pain Relief Get FDA's Unapproved Stamp
This article was originally published in The Pink Sheet
Executive Summary
FDA warning based on an inspection of AIG Technologies' facility from September through November 2015. The firm responded without "supporting documentation" to FDA and the agency has been unable to verify the adequacy of its corrective actions.